🇺🇸 FDA
Patent

US 10857265

Injectable composition for in-situ repair and regeneration of an injured ligament or tendon and methods of use

granted A61KA61K35/12A61K35/16

Quick answer

US patent 10857265 (Injectable composition for in-situ repair and regeneration of an injured ligament or tendon and methods of use) held by United States Government as represented by the Department of Veterans Affairs expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K35/12, A61K35/16, A61K38/28, A61K45/06